thumbnail image

seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LungCanSeek
    • OncoGate
    • LeukoPrint
    • OncoGraph
    • PanCanSeek
    • SeekInEZ
    • EGFRseek
    • PHLseek
    • SeekInJoy
    • PetCanSeek
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LungCanSeek
      • OncoGate
      • LeukoPrint
      • OncoGraph
      • PanCanSeek
      • SeekInEZ
      • EGFRseek
      • PHLseek
      • SeekInJoy
      • PetCanSeek
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry

seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LungCanSeek
    • OncoGate
    • LeukoPrint
    • OncoGraph
    • PanCanSeek
    • SeekInEZ
    • EGFRseek
    • PHLseek
    • SeekInJoy
    • PetCanSeek
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LungCanSeek
      • OncoGate
      • LeukoPrint
      • OncoGraph
      • PanCanSeek
      • SeekInEZ
      • EGFRseek
      • PHLseek
      • SeekInJoy
      • PetCanSeek
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry

All Categories - SeekIn

SeekIn Study Highlights the Economic Value of FIT-Based Colorectal Cancer Screening

12 de agosto de 2026 · Press Releases
Modeling analysis suggests that FIT-based screening could substantially reduce colorectal cancer...

SeekIn Receives TÜV SÜD Confirmation for EU IVDR Transition of Six IVD Products

28 de julio de 2026 · Press Releases
Formal application and written agreement support continued EU market access under the IVDR...

SeekIn to Present Seven Clinical Studies at ASCO 2026 Highlighting Advances in Multi-Cancer Early Detection and Hematologic Malignancies

25 de mayo de 2026 · Press Releases
SAN DIEGO, CA — May 27, 2026 — SeekIn Inc. (“SeekIn”), a leader in next-generation sequencing ...

SeekIn Showcases the Advances in Multi‑Cancer Early Detection, Risk Stratification, and Treatment Monitoring at AACR 2026 Annual Meeting

16 de abril de 2026 · Press Releases
San Diego, CA – April 16, 2026 – SeekIn Inc., a global leader in affordable multi‑cancer early...

SeekIn’s OncoSeek Multi-Cancer Early Detection Technology Receives U.S. Patent Grant

10 de abril de 2026 · Press Releases
San Diego, CA – April 3, 2026 – SeekIn Inc. (“SeekIn”), a leader in blood-based cancer early...

SeekIn Inc. launches OncoGate, an AI-powered cancer risk assessment to make multi-cancer early detection screening scalable worldwide

7 de abril de 2026 · Press Releases
San Diego, USA – April 20, 2026 – SeekIn Inc., a global leader in blood-based multi-cancer early...

SeekIn Announces Launch of OncoSeek Multi‑Cancer Early Detection Test in Costa Rica

15 de enero de 2026 · Press Releases
San Diego, USA – SeekIn, a global leader in blood‑based cancer detection, today announced the...

Seekln 2025 Annual Report:Milestones in Our Journey

29 de diciembre de 2025 · Press Releases
Shenzhen, China and San Diego, USA – December 29, 2025 – SeekIn Inc. today reported a landmark...

SeekIn Inc. Announces Publication in Blood Advances Demonstrating That Genome‑Wide Copy Number Profiling Enhances Risk Stratification in Multiple Myeloma

17 de diciembre de 2025 · Press Releases
Shenzhen, China and San Diego, USA – December 17, 2025 – SeekIn Inc., a global leader in blood...

SeekIn Inc. presents three studies at the 67th American Society of Hematology (ASH) Annual Meeting in Orlando

8 de diciembre de 2025 · Press Releases
Orlando, Florida — December 8, 2025 — SeekIn Inc. announced that three clinical studies featuring...

SeekIn Showcases Cost-Effective Two-Step Multi-Cancer Screening Strategy and Pan-Cancer Treatment Monitoring Breakthrough at CNAPS 2025

4 de diciembre de 2025 · Press Releases
Hong Kong, China – December 4, 2025 - SeekIn Inc., a biotech company specializing in blood-based...

Product Launch | OncoGraph: A New Era of Accessible Personalized Tumor Monitoring

27 de noviembre de 2025 · Press Releases
SeekIn Inc. announces the launch of OncoGraph, an innovative blood test designed to deliver...

OncoInv signs distribution agreement for OncoSeek® in El Salvador - SeekIn's partner OncoInv signs distribution agreement for OncoSeek® in El Salvador

27 de noviembre de 2025 · Media Resources
El Salvador - November 27, 2025 - OncoInv has signed a new distribution partnership with MaxBloch...

SeekIn to Present Four New Studies Advancing Cost-Effective Multi-Cancer Early Detection at the 2025 Early Detection of Cancer Conference

20 de octubre de 2025 · Press Releases
Portland, Oregon — October 20, 2025 — SeekIn Inc., a leader in liquid biopsy-based cancer...

Large-scale Multi-Center Study Validates OncoSeek®: Transformative, Affordable AI Blood Test for Multi-Cancer Early Detection

9 de octubre de 2025 · Press Releases
San Diego, USA — October 9, 2025 — SeekIn Inc., a leading innovator in liquid biopsy-based cancer...

SeekIn Expanding Lung Cancer Screening With Low-Cost Blood Test

7 de octubre de 2025 · Media Resources
NEW YORK - October 7, 2025 - Bolstered by recent study results, cancer diagnostics firm SeekIn is...

LungCanSeek: New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer

1 de octubre de 2025 · Press Releases
San Diego, USA – October 1, 2025 - SeekIn Inc., a leading innovator in liquid biopsy-based cancer...

SeekIn’s OncoSeek® test Recognized in China’s Expert Consensus on Multi-Cancer Early Detection

8 de agosto de 2025 · Press Releases
Shenzhen, China - August 7, 2025 - SeekIn Inc., a leading innovator in liquid biopsy-based cancer...

SeekIn Secures Five U.S. Trademarks for Breakthrough Cancer Diagnostic Tests, Capping Global IP Expansion

27 de julio de 2025 · Press Releases
San Diego, July 28, 2025 - SeekIn Inc., a leader in blood-based early cancer detection and...

SeekInClarity: Blood-Based Multi-Omics Test Offers Promising Advance in Monitoring Cancer Treatment Response

3 de julio de 2025 · Media Resources
San Diego, July 2, 2025 -- A new prospective study published in BMC Cancer demonstrates that a...
More Posts
  • SeekIn envisions that by leading a new norm for cancer early detection the clinical outcome of mid-/late-stage cancer patients can be reversed and the cancer mortality rate can be reduced by 15%.

    Explore SeekIn's products
  •  

    Newsroom

    SeekIn Study Highlights the Economic Value of FIT-Based Colorectal Cancer...

    12 de agosto de 2026 · Press Releases

    SeekIn Receives TÜV SÜD Confirmation for EU IVDR Transition of Six IVD...

    28 de julio de 2026 · Press Releases

    SeekIn to Present Seven Clinical Studies at ASCO 2026 Highlighting Advances...

    25 de mayo de 2026 · Press Releases

    SeekIn Showcases the Advances in Multi‑Cancer Early Detection, Risk Stratification...

    16 de abril de 2026 · Press Releases

    SeekIn’s OncoSeek Multi-Cancer Early Detection Technology Receives ...

    10 de abril de 2026 · Press Releases

    SeekIn Inc. launches OncoGate, an AI-powered cancer risk assessment ...

    7 de abril de 2026 · Press Releases
    More Posts

Navigation

Technology

SeekInCare

SeeInCure

SeekInClarity

OncoSeek

Research

Contact Us

10320 Camino Santa Fe, Suite G

San Diego, CA 92121

United States

info@seekincancer.com

© 2024 SeekIn Inc.

All Rights Reserved.

Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More